• AI
  • Molecular Imaging
  • CT
  • X-Ray
  • Ultrasound
  • MRI
  • Facility Management
  • Mammography

Acuson and ATL settle patent dispute

Article

Acuson and Advanced Technology Laboratories last week settleda patent dispute between the ultrasound competitors relating tomultiplane transesophageal (TEE) technology and an ultrasoundfocusing technique. The settlement ends lawsuits that had beenfiled

Acuson and Advanced Technology Laboratories last week settleda patent dispute between the ultrasound competitors relating tomultiplane transesophageal (TEE) technology and an ultrasoundfocusing technique. The settlement ends lawsuits that had beenfiled last year in federal courts in Washington and California.

ATL had claimed that Acuson was infringing on its TEE patents,while Acuson charged ATL will violating its patent for an ultrasoniclens with reduced delay range. As part of the settlement, Acusonagreed to pay ATL an undisclosed sum in royalty payments on TEEprobes it sells. The companies entered a cross-licensing agreementfor several patents, including the Acuson focusing patent.

Recent Videos
Emerging Research at SNMMI Examines 18F-flotufolastat in Managing Primary and Recurrent Prostate Cancer
Could Pluvicto Have a Role in Taxane-Naïve mCRPC?: An Interview with Oliver Sartor, MD
New SNMMI President Cathy Cutler, PhD, Discusses Current Challenges and Goals for Nuclear Medicine
Where the USPSTF Breast Cancer Screening Recommendations Fall Short: An Interview with Stacy Smith-Foley, MD
A Closer Look at MRI-Guided Transurethral Ultrasound Ablation for Intermediate Risk Prostate Cancer
Improving the Quality of Breast MRI Acquisition and Processing
Can Fiber Optic RealShape (FORS) Technology Provide a Viable Alternative to X-Rays for Aortic Procedures?
Does Initial CCTA Provide the Best Assessment of Stable Chest Pain?
Making the Case for Intravascular Ultrasound Use in Peripheral Vascular Interventions
Can Diffusion Microstructural Imaging Provide Insights into Long Covid Beyond Conventional MRI?
Related Content
© 2024 MJH Life Sciences

All rights reserved.